Broncus Medical Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Broncus Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012872
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies. The company’s products comprise lungpoint virtual bronchoscopic navigation system, lungpoint satellite planning system, and flexneedle. Its lungpoint virtual bronchoscopic navigation system provides real time navigation within lungs for lung biopsy and other DX and TX procedures. Broncus’s product simultaneously shows the live and virtual views and the path to follow. The company offers therapeutic technologies for the treatment of lung diseases. Its flexneedle provides ability to reach lesions in the peripheral segments of the lung. Broncus is headquartered in San Jose, California, the US.

Broncus Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Broncus Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Broncus Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Broncus Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Broncus Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Broncus Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Broncus Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Uptake Medical Raises Additional USD0.4 Million Financing 10
Uptake Medical Raises USD2 Million Financing 11
Uptake Medical Secures USD40.25 Million in Venture Funding 12
Uptake Medical Secures US$35.1 Million In Series C Financing 13
Uptake Medical Secures US$4.9 Million In Financing Round 15
Partnerships 16
LifeTech Scientific, DiNova Venture Partners, Themes Investment Partners And Broncus Technologies Partner To Form Broncus Medical 16
Asset Transactions 17
PneumRx Acquires Patents And Domain Names From Broncus Technologies 17
Acquisition 18
Broncus Medical Acquires Uptake Medical 18
Broncus Medical Inc – Key Competitors 19
Broncus Medical Inc – Key Employees 20
Broncus Medical Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Broncus Medical Inc, Medical Equipment, Key Facts 2
Broncus Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Broncus Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Broncus Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Broncus Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Broncus Medical Inc, Deals By Market, 2011 to YTD 2017 8
Broncus Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Uptake Medical Raises Additional USD0.4 Million Financing 10
Uptake Medical Raises USD2 Million Financing 11
Uptake Medical Secures USD40.25 Million in Venture Funding 12
Uptake Medical Secures US$35.1 Million In Series C Financing 13
Uptake Medical Secures US$4.9 Million In Financing Round 15
LifeTech Scientific, DiNova Venture Partners, Themes Investment Partners And Broncus Technologies Partner To Form Broncus Medical 16
PneumRx Acquires Patents And Domain Names From Broncus Technologies 17
Broncus Medical Acquires Uptake Medical 18
Broncus Medical Inc, Key Competitors 19
Broncus Medical Inc, Key Employees 20
Broncus Medical Inc, Subsidiaries 21
Broncus Medical Inc, Joint Venture 21

★海外企業調査レポート[Broncus Medical Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Securities Co., Ltd. (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • JHL Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • Ecopetrol S.A.:企業の戦略・SWOT・財務情報
    Ecopetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Ecopetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ContraVir Pharmaceuticals Inc (CTRV):企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Electro Optic Systems Holdings Ltd (EOS):企業の財務・戦略的SWOT分析
    Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Marksmen Energy Inc (MAH):企業の財務・戦略的SWOT分析
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd, is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, manages, produces and develops oil and gas properties in Western Canada …
  • MSM Malaysia Holdings Berhad (MSM):企業の財務・戦略的SWOT分析
    MSM Malaysia Holdings Berhad (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bausch & Lomb Incorporated:企業のM&A・事業提携・投資動向
    Bausch & Lomb Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bausch & Lomb Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Patterson-UTI Energy, Inc. (PTEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Patterson-UTI Energy Inc (Patterson) is an oilfield service provider. It offers onshore contract drilling and pressure pumping services to oil and gas exploration and production companies. The company offers pressure pumping services such as well stimulation and cementing for completion of n …
  • Dako AS-医療機器分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • DHL International GmbH:企業の戦略的SWOT分析
    DHL International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Insperity Inc (NSP):企業の財務・戦略的SWOT分析
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PT. Millennium Pharmacon International TBK (SDPC):企業の財務・戦略的SWOT分析
    PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Petroleos de Venezuela SA-エネルギー分野:企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • Juno Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Juno Therapeutics Inc (Juno) is a clinical-stage company that develops novel cellular immunotherapies. The company formulates cell-based cancer immunotherapies based on platforms such as chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells …
  • Coherus BioSciences Inc (CHRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • Welltec AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Welltec AS (Welltec) is an oil and gas service provider that develops and offers well technologies and solutions for the oil and gas industries. The company's solutions include wireline services, milling solutions, robotic well solutions, conveyance solutions, clean-out solutions, and mechan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆